Showing results (21-30 of 60) with videos related to
Sort By:
Pageof 6
Investigational New Drugs|April 12, 2000
A sensitive docetaxel assay in plasma by solid-phase extraction and high performance liquid chromatography-UV detection: validation and suitability in phase I clinical trial pharmacokineticsC J Ardiet, B Tranchand, S Zanetta, et al.Cancer Chemotherapy and Pharmacology|January 1, 1993
Phase II study of fotemustine as second-line treatment after failure of immunotherapy in metastatic renal cell carcinomaC Lasset, Y Merrouche, S Negrier, et al.Lung Cancer (Amsterdam, Netherlands)|September 12, 2001
Dose-finding, pharmacokinetic and phase II study of docetaxel in combination with gemcitabine in patients with inoperable non-small cell lung cancerP Rebattu, X Quantin, C Ardiet, et al.Annales D'Endocrinologie|January 1, 1988
[Cushing's syndrome caused by ectopic production of CRF by a medullary carcinoma of the thyroid body]J Tourniaire, B Rebattu, B Conte-Devolx, et al.Bulletin Du Cancer|July 9, 2013
[Identification of occupational exposures among patients with lung cancer]Camille Cellier, Barbara Charbotel, Julien Carretier, et al.Revue De Pneumologie Clinique|July 6, 2000
[Phase II trial with cystemustine (60 mg/m2) in advanced or metastatic pretreated lung carcinoma]P Rebattu, B Coudert, M Schneider, et al.Chest|August 1, 1992
Pretreatment staging evaluation in small cell lung carcinoma. A new approach to medical decision makingF Chauvin, V Trillet, I Court-Fortune, et al.Bulletin Du Cancer|January 1, 1987
[High-doses chemotherapy followed by bone marrow autograft in the treatment of small cell bronchial cancer]J L Pico, D Baume, M Ostronoff, et al.European Journal of Cancer (Oxford, England : 1990)|January 1, 1993
Phase II study of cystemustine in metastatic colorectal carcinoma. A trial of the EORTC Clinical Screening GroupP Kerbrat, A Adenis, P Rebattu, et al.Le Poumon Et Le Coeur|January 1, 1983
[Localized pulmonary pseudo-tumoral form of Wegener's disease and fulminating evolution. Apropos of a case]D Gindre, R Cahen, P Rebattu, et al.Pageof 6